Lynn Hall
Last active: 7/6/2017


None provided


The following timeline graph is generated from all co-authored publications.

  1. Azithromycin Causes a Novel Proarrhythmic Syndrome. Yang Z, Prinsen JK, Bersell KR, Shen W, Yermalitskaya L, Sidorova T, Luis PB, Hall L, Zhang W, Du L, Milne G, Tucker P, George AL, Campbell CM, Pickett RA, Shaffer CM, Chopra N, Yang T, Knollmann BC, Roden DM, Murray KT (2017) Circ Arrhythm Electrophysiol 10(4)
    › Citation · 28408648 (PubMed) · PMC5396181 (PubMed Central)
  2. Contrasting Nav1.8 Activity in Scn10a-/- Ventricular Myocytes and the Intact Heart. Stroud DM, Yang T, Bersell K, Kryshtal DO, Nagao S, Shaffer C, Short L, Hall L, Atack TC, Zhang W, Knollmann BC, Baudenbacher F, Roden DM (2016) J Am Heart Assoc 5(11)
    › Citation · 27806966 (PubMed) · PMC5210363 (PubMed Central)
  3. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Yang T, Atack TC, Stroud DM, Zhang W, Hall L, Roden DM (2012) Circ Res 111(3): 322-32
    › Citation · 22723299 (PubMed) · PMC3412150 (PubMed Central)
  4. Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice. Lowe JS, Stroud DM, Yang T, Hall L, Atack TC, Roden DM (2012) Cardiovasc Res 95(3): 300-7
    › Citation · 22562703 (PubMed) · PMC3633400 (PubMed Central)
  5. Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL, Roden DM (2011) Circulation 124(9): 1001-11
    › Citation · 21824921 (PubMed) · PMC3297976 (PubMed Central)
  6. Informatic and functional approaches to identifying a regulatory region for the cardiac sodium channel. Atack TC, Stroud DM, Watanabe H, Yang T, Hall L, Hipkens SB, Lowe JS, Leake B, Magnuson MA, Yang P, Roden DM (2011) Circ Res 109(1): 38-46
    › Citation · 21566215 (PubMed) · PMC3135383 (PubMed Central)
  7. Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases. Mitchell S, Ellingson C, Coyne T, Hall L, Neill M, Christian N, Higham C, Dobrowolski SF, Tuchman M, Summar M, Urea Cycle Disorder Consortium (2009) Hum Mutat 30(1): 56-60
    › Citation · 18666241 (PubMed)
  8. Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study. Canter JA, Summar ML, Smith HB, Rice GD, Hall LD, Ritchie MD, Motsinger AA, Christian KG, Drinkwater DC, Scholl FG, Dyer KL, Kavanaugh-McHugh AL, Barr FE (2007) Mitochondrion 7(3): 204-10
    › Citation · 17188582 (PubMed) · PMC1929167 (PubMed Central)
  9. The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency. Eeds AM, Hall LD, Yadav M, Willis A, Summar S, Putnam A, Barr F, Summar ML (2006) Mol Genet Metab 89(1-2): 80-6
    › Citation · 16737834 (PubMed)
  10. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Kallianpur AR, Hall LD, Yadav M, Byrne DW, Speroff T, Dittus RS, Haines JL, Christman BW, Summar ML (2005) Bone Marrow Transplant 35(12): 1155-64
    › Citation · 15834437 (PubMed)